Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 20, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

February 8, 2017

Conditions
Healthy Volunteers
Interventions
DRUG

Ibuprofen

Fixed dose combination

DRUG

Pseudoephedrine-HCl

Fixed dose combination

Trial Locations (1)

9301

Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY